2024/25 Taught Postgraduate Programme Catalogue

MSc Biopharmaceutical Development

Total credits: 180

Entry requirements:

Entry Requirements are available on the Course Search entry

School/Unit responsible for the parenting of students and programme:

Faculty of Biological Sciences

Examination board through which the programme will be considered:

The Masters Bioscience Exam Board

Relevant QAA Subject Benchmark Groups:

Subject benchmark statements for biological sciences Masters programmes do not exist. However, students will be expected to demonstrate the characteristics embodied in the QAA Qualifications Frameworks level descriptors for Masters degrees (https://www.qaa.ac.uk/docs/qaa/quality-code/master's-degree-characteristics-statement.pdf?sfvrsn=6ca2f981_10)

Programme specification:

The programme will provide integrated understanding of the industrial pathway of biological drug discovery, development and exploitation. Modules exist for each of the major technical functions of this industry (discovery, manufacturing, pre-clinical testing, clinical safety and efficacy, laboratory analytical skills). Further modules introduce the course & industry (pathway, regulatory framework, economic value, and societal drivers), to address commercialisation of biopharmaceutical products and a final taught module that integrates topics in the form of project work submitting a new biochemical entity to a regulatory body. This will provide students with a deep understanding of core elements of the discipline, and a good appreciation of the broader context and regulatory framework of the industry. It is highly interdisciplinary, and will equip students to work in such teams.

There will be a strong emphasis on the acquisition of technical skills necessary for biological drug development and so a substantial component of the programme will be devoted to practical training including a taught practical skills module (Practical Skills for a Regulatory Environment). The practical skills module will introduce students to the techniques used in the biopharma industry and the standards to which they are applied within a regulatory environment. Thus students will perform a series of experiments demonstrating stages along the drug development pathway working under GLP/GMP/GCP instruction as far as is possible within university laboratories. Topics covered will include: assay validation (accuracy, precision, robustness, in-specification), followed by two practical strands; one focusing on molecular/biophysical protein characterisation (GMP-focus; antibody purification, SDS-PAGE, bio-potency activity assay by ELISA, binding assay by e.g. SPR) and the second on cell-based assays (GCP-focus; flow cytometry, confocal microscopy, cell growth/viability). During the research project, students will have the opportunity to apply this training, thus building on, and extending these skills.

Year1 - View timetable

[Learning Outcomes, Transferable (Key) Skills, Assessment]

Compulsory modules:

Candidates will be required to study the following compulsory modules:

Last updated: 29/08/2024 16:04:11

Disclaimer

Browse Other Catalogues

• Undergraduate module catalogue
• Taught Postgraduate module catalogue
• Undergraduate programme catalogue
• Taught Postgraduate programme catalogue

Errors, omissions, failed links etc should be notified to the Catalogue Team.PROD